Compare Kalbe Farma Tbk (KLBF) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kalbe Farma Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp735 (market cap 35.34T, 108.3M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Kalbe Farma Tbk is far larger — about 338.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KLBF | SCPI | |
|---|---|---|
Market Cap | 35.34T | 104.4B |
Volume | 108.3M | — |
Lot | 1.08M | — |
Turnover | 80.02B | — |
Average Price | 738.89 | — |
Value | 80.02B | — |
Indicative Equilibrium Price | 735 | — |
Indicative Equilibrium Volume | 59.74K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kalbe Farma Tbk
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
